Literature DB >> 21242341

Screening for osteoporosis: U.S. preventive services task force recommendation statement.

.   

Abstract

DESCRIPTION: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for osteoporosis.
METHODS: The USPSTF evaluated evidence on the diagnostic accuracy of risk assessment instruments for osteoporosis and fractures, the performance of dual-energy x-ray absorptiometry and peripheral bone measurement tests in predicting fractures, the harms of screening for osteoporosis, and the benefits and harms of drug therapy for osteoporosis in women and men. RECOMMENDATIONS: The USPSTF recommends screening for osteoporosis in women aged 65 years or older and in younger women whose fracture risk is equal to or greater than that of a 65-year-old white woman who has no additional risk factors. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis in men. (I statement).

Entities:  

Mesh:

Year:  2011        PMID: 21242341     DOI: 10.7326/0003-4819-154-5-201103010-00307

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  153 in total

1.  The use of computed tomography attenuation to evaluate osteoporosis following acute fractures of the thoracic and lumbar vertebra.

Authors:  Osa Emohare; Amanda Cagan; Robert Morgan; Rick Davis; Martin Asis; Julie Switzer; David W Polly
Journal:  Geriatr Orthop Surg Rehabil       Date:  2014-06

2.  Secondary fracture prevention.

Authors:  Robert A Adler
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

3.  Bone density testing intervals and common sense.

Authors:  E Michael Lewiecki; Neil Binkley
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

Review 4.  Bone Density Screening and Re-screening in Postmenopausal Women and Older Men.

Authors:  Margaret L Gourlay; Robert A Overman; Kristine E Ensrud
Journal:  Curr Osteoporos Rep       Date:  2015-12       Impact factor: 5.096

5.  Duration of anti-resorptive therapy for osteoporosis.

Authors:  Robert A Adler
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

6.  Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.

Authors:  Carolyn J Crandall; Joseph Larson; Nicole C Wright; Deepika Laddu; Marcia L Stefanick; Andrew M Kaunitz; Nelson B Watts; Jean Wactawski-Wende; Catherine R Womack; Karen C Johnson; Laura D Carbone; Rebecca D Jackson; Kristine E Ensrud
Journal:  JAMA Intern Med       Date:  2020-09-01       Impact factor: 21.873

7.  FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.

Authors:  R C Hamdy; E Seier; K Whalen; W A Clark; K Hicks; T B Piggee
Journal:  Osteoporos Int       Date:  2018-02-03       Impact factor: 4.507

8.  Evaluation and treatment of osetoporotic distal radius fracture in the elderly patient.

Authors:  Eric M Padegimas; Daniel A Osei
Journal:  Curr Rev Musculoskelet Med       Date:  2013-03

9.  Overuse of short-interval bone densitometry: assessing rates of low-value care.

Authors:  N E Morden; W L Schpero; R Zaha; T D Sequist; C H Colla
Journal:  Osteoporos Int       Date:  2014-05-09       Impact factor: 4.507

10.  Osteoporosis screening in postmenopausal women 50 to 64 years old: comparison of US Preventive Services Task Force strategy and two traditional strategies in the Women's Health Initiative.

Authors:  Carolyn J Crandall; Joseph Larson; Margaret L Gourlay; Meghan G Donaldson; Andrea LaCroix; Jane A Cauley; Jean Wactawski-Wende; Margery L Gass; John A Robbins; Nelson B Watts; Kristine E Ensrud
Journal:  J Bone Miner Res       Date:  2014-07       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.